{"id":481463,"date":"2026-02-17T20:51:08","date_gmt":"2026-02-17T20:51:08","guid":{"rendered":"https:\/\/www.newsbeep.com\/ca\/481463\/"},"modified":"2026-02-17T20:51:08","modified_gmt":"2026-02-17T20:51:08","slug":"compass-pathways-soars-as-psilocybin-depression-treatment-hits-second-phase-3-trial-goals-endpoints-news","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/ca\/481463\/","title":{"rendered":"Compass Pathways soars as psilocybin depression treatment hits second Phase 3 trial goals &#8211; Endpoints News"},"content":{"rendered":"<p><a href=\"https:\/\/news.google.com\/rss\/articles\/CBMihgFBVV95cUxQMndIc0FTREhBcXZ2c2UwbUo2WTNFZnNCaVdTRnc1TGFHTlpyQ21Yc1FKVlJGOHQ5VU50SllwczNfNDB1TVJMOXZ6NDNuVFllMTlKb0tZdF81ZjNZOHAtWFJqRU0zY1BwQ0taYVo0RlFTdUd4dktZVGN2T1B2eWgtZk8zT3ZYQQ?oc=5\" target=\"_blank\" rel=\"nofollow noopener\">Compass Pathways soars as psilocybin depression treatment hits second Phase 3 trial goals<\/a>&nbsp;&nbsp;Endpoints News<a href=\"https:\/\/news.google.com\/rss\/articles\/CBMijwJBVV95cUxPQTVzd3NRdktVSV9pM3k1YUp0TkdfY1JHaWpZRVdGQmlCYmxaOFpvNnIxbUVoX1p4OEhjZVFzX1lsc1NZd2RlS0g1VzJGZUh2ZTg0VUR4VmVubENEM19PdjZGcmJCdnFEUU1MMzRDejNxVnpYZEVjQ0NXZGNpLTdzeng2WUFwaG9fbTRQaEpCSU8xbmdjT1AtTS1QZHBZZnlyRDdOOUw3ZVNOMUtobi0yX2xIdllDR2x2N0VGRzlhdUp0YlhKQkt1b2JxQmdqeUpIclUxMEI2S2xmTmE3bVRBVEVMSDdya0ZldmRDdVgtQklZZXpsTU1LaGl2cFpOVFVkMDlTSWRsQXdtR3E2aDhz?oc=5\" target=\"_blank\" rel=\"nofollow noopener\">Compass Pathways Successfully Achieves Primary Endpoint in Second Phase 3 Trial Evaluating COMP360 Psilocybin for Treatment-Resistant Depression<\/a>&nbsp;&nbsp;Investing News Network<a href=\"https:\/\/news.google.com\/rss\/articles\/CBMivwFBVV95cUxOY3g0ZDdkZ0dGcDFsSUZxWjlNOWdyTjBLTzh4bHNGeWhCU2pVWDlJM3p2Q0VRVXA3YVkzN045ZVptSzFxbzB0WmRNaFg3SjRQa0lMV0l5ZDR3bDBRMUxQbXZ5RlRsQV84YjRmblpRTGNrVHZ1NHJXZXlZUm9JMFM1YVNpU1VLdXRmQTZvMkp0dTllVl9ZMExNZDVTNzFWcTFWbnY0TC1rZHo1YXR0ejBlQ09wczVrSmg5VTFJLWFIZw?oc=5\" target=\"_blank\" rel=\"nofollow noopener\">Compass Pathways to release new clinical data on psilocybin trials By Investing.com<\/a>&nbsp;&nbsp;Investing.com Canada<a href=\"https:\/\/news.google.com\/rss\/articles\/CBMiygFBVV95cUxQTklhOVhINnlFN01FNG1ydTRsN3VkNGJiakVKWWxuREJzakl6bENyb1RJOFFUUFNpbHI3TEdvSnFsbWQtVnlVS0VCU2dfU0Vad0VKV1laRERMZXlPWHdkX3VxU1lndjdTeFpjNm1MQ1hIUlg5Mk1Sd2NpRV9vcE94bjFkRGd5eVVzYmx5aUFqQV9jNTJVeFlYamk4UlB0SVF5ZWNwbUhtNElnODZETEdZaU0xUm16a2w3S2VHLTA5ZUR6R0dpejZ2eV93?oc=5\" target=\"_blank\" rel=\"nofollow noopener\">BREAKING: Second Positive Phase 3 for Compass\u2019 Psilocybin, Though Modest Magnitude Raises Questions<\/a>&nbsp;&nbsp;Psychedelic Alpha<a href=\"https:\/\/news.google.com\/rss\/articles\/CBMi0AFBVV95cUxQQlA0Z2lyT2JuOE9pYUJpN2wxOEpuTW41eEtfQnhteVBLZWptZVVZUHVBbFl6TG5FX2FVcEozNU9PR2hJU0p4a2g5QkZqM3ZOekZ2aHJsZ0VscjFUY2hqY0diQTl1TEJEeU5UNnNjcHFQS0VNVVNMY0dPQ1dEaFBlVmN2Vm9Fa2cyV2hsVmhxaGlkVFZkNTdOQVJwLW9CZThYVzJ6Y0hVbGtmUUc4TEdnZ1hZQW9aejBBdER2OHdNVl9TZjJsTGgtR1BxRUpqU013?oc=5\" target=\"_blank\" rel=\"nofollow noopener\">Compass Pathways to Announce New Clinical Data from Two Ongoing Phase 3 Trials<\/a>&nbsp;&nbsp;Business Wire<\/p>\n","protected":false},"excerpt":{"rendered":"Compass Pathways soars as psilocybin depression treatment hits second Phase 3 trial goals&nbsp;&nbsp;Endpoints NewsCompass Pathways Successfully Achieves Primary&hellip;\n","protected":false},"author":2,"featured_media":481464,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[35],"tags":[49,48,3184,194644,10896,84,194645,393,394,9080,194646,66764,67320],"class_list":{"0":"post-481463","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-mental-health","8":"tag-ca","9":"tag-canada","10":"tag-clinical-trials","11":"tag-compass-pathways","12":"tag-fda-approval","13":"tag-health","14":"tag-madrs-scale","15":"tag-mental-health","16":"tag-mentalhealth","17":"tag-psilocybin","18":"tag-psychiatric-treatment","19":"tag-rd","20":"tag-treatment-resistant-depression"},"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts\/481463","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/comments?post=481463"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts\/481463\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/media\/481464"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/media?parent=481463"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/categories?post=481463"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/tags?post=481463"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}